Chemical Structure : ATR-101
CAS No.: 133825-81-7
Catalog No.: PC-70112Not For Human Use, Lab Use Only.
ATR-101 (PD-132301, Nevanimibe) is a selective and potent inhibitor of ACAT1 with IC50 of 52 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $248 | In stock | |
10 mg | $388 | In stock | |
25 mg | $598 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ATR-101 (PD-132301, Nevanimibe) is a selective and potent inhibitor of ACAT1 with IC50 of 52 nM.
ATR-101 (PD-132301, Nevanimibe) induces H295R cell apoptosis, causes mitochondrial hyperpolarization, reactive oxygen release, and ATP depletion, caspase-3/7 activation, and membrane permeabilization.
ATR-101 (PD-132301, Nevanimibe) decreases the formation of cholesteryl esters and increases FC levels in H295R adrenocortical carcinoma cells.
ATR-101 (PD-132301, Nevanimibe) inhibits the establishment and impeds the growth of ACC-derived H295R cell xenografts in mice; orally active.
M.Wt | 458.09 | |
Formula | C27H40ClN3O | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
1-(2,6-diisopropylphenyl)-3-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride |
1. LaPensee CR, et al. Endocrinology. 2016 May;157(5):1775-88.
2. Trivedi BK, et al. J Med Chem. 1994 May 27;37(11):1652-9.
3. Cheng Y, et al. Endocr Relat Cancer. 2016 Apr;23(4):1-19.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright